← Back to Clinical Trials
Recruiting NCT07433712

NCT07433712 Project REACH: A Comprehensive Telehealth Intervention at Syringe Service Programs to Engage People Who Use Drugs

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07433712
Status Recruiting
Phase
Sponsor University of Minnesota
Condition Substance Use
Study Type INTERVENTIONAL
Enrollment 121 participants
Start Date 2026-05-06
Primary Completion 2028-05-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Project REACH

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 121 participants in total. It began in 2026-05-06 with a primary completion date of 2028-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This trial will assess the feasibility, acceptability, and preliminary effectiveness of Project REACH (Remote Engagement \& Access for Community Health), a telehealth intervention at syringe service programs (SSP) to improve access to HIV-related evidence-based interventions (EBI) for people who use drugs including those who inject them.

Eligibility Criteria

People Who Use Drugs Inclusion Criteria: * 18 years of age or older * able to speak and understand English * have used an illicit substance at least once in the past year * have lived in the study area (in or near their city of their recruitment) for at least 6 months * have active health insurance by the start of the Project REACH trial date People Who Use Drugs Exclusion Criteria: * Unable or unwilling to provide informed consent Stakeholder Inclusion Criteria: * 18 years of age or older * able to speak and understand English * currently employed or volunteering with the PCC or an SSP enrollment site for at least one year at the time of the interview OR hired as a study navigator at one of the four enrollment sites Stakeholder Exclusion Criteria: * Unable or unwilling to provide informed consent

Contact & Investigator

Central Contact

Kumi Smith

✉ smi00831@umn.edu

📞 612-301-3051

Frequently Asked Questions

Who can join the NCT07433712 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Substance Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07433712 currently recruiting?

Yes, NCT07433712 is actively recruiting participants. Contact the research team at smi00831@umn.edu for enrollment information.

Where is the NCT07433712 trial being conducted?

This trial is being conducted at Minneapolis, United States.

Who is sponsoring the NCT07433712 clinical trial?

NCT07433712 is sponsored by University of Minnesota. The trial plans to enroll 121 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology